佐力药业2月24日获融资买入1847.99万元，融资余额5.92亿元

Group 1 - Zhaoli Pharmaceutical's stock increased by 1.75% on February 24, with a trading volume of 160 million yuan. The financing buy amount was 18.48 million yuan, while the financing repayment was 21.25 million yuan, resulting in a net financing buy of -2.77 million yuan. The total financing and securities balance reached 595 million yuan [1] - The financing balance of Zhaoli Pharmaceutical was 592 million yuan, accounting for 5.00% of the circulating market value, which is above the 70th percentile level over the past year, indicating a high position [1] - On the same day, Zhaoli Pharmaceutical repaid 7,200 shares in securities lending and sold 23,600 shares, with a selling amount of 398,400 yuan. The securities lending balance was 287,740 yuan, exceeding the 90th percentile level over the past year, also indicating a high position [1] Group 2 - As of September 30, Zhaoli Pharmaceutical had 41,400 shareholders, an increase of 7.31% from the previous period. The average circulating shares per person decreased by 6.82% to 14,562 shares [2] - For the period from January to September 2025, Zhaoli Pharmaceutical achieved an operating income of 2.28 billion yuan, a year-on-year increase of 11.48%. The net profit attributable to the parent company was 510 million yuan, reflecting a year-on-year growth of 21.00% [2] - Zhaoli Pharmaceutical has distributed a total of 1.442 billion yuan in dividends since its A-share listing, with 942 million yuan distributed over the past three years [3]